A Review of the Effects of Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors on Lean Body Mass in Humans

Weight loss is an important goal in the management of several chronic conditions, including type 2 diabetes mellitus, and pharmacological therapies that aid weight loss are appealing. Glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter 2 inhibitors (SGLT2is) are nov...

Descripción completa

Detalles Bibliográficos
Autores principales: Sargeant, Jack Alistair, Henson, Joseph, King, James Adam, Yates, Thomas, Khunti, Kamlesh, Davies, Melanie Jane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Endocrine Society 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769337/
https://www.ncbi.nlm.nih.gov/pubmed/31565876
http://dx.doi.org/10.3803/EnM.2019.34.3.247

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769337/
https://www.ncbi.nlm.nih.gov/pubmed/31565876
http://dx.doi.org/10.3803/EnM.2019.34.3.247

Ejemplares similares